Scholl Hendrik Peter's Form 4 filing
Belite Bio, Inc (BLTE) · filed Jun 22, 2026
- Accession no.
- 0001193125-26-276615
- Filed
- Jun 22, 2026
- Trade date
- Jun 18, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions. Open-market sales total $1.45M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Scholl Hendrik PeterCIK 0002113223 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | American depositary share | SSaleDisposed | −96 | $143.90 | −$13,814.4 | 24,904 | Indirect | |
| Jun 18, 2026 | American depositary share | SSaleDisposed | −3,748 | $144.66F2 | −$542,185.68 | 21,156 | Indirect | |
| Jun 18, 2026 | American depositary share | SSaleDisposed | −4,861 | $145.43F3 | −$706,935.23 | 16,295 | Indirect | |
| Jun 18, 2026 | American depositary share | SSaleDisposed | −1,199 | $146.24F4 | −$175,341.76 | 15,096 | Indirect | |
| Jun 18, 2026 | American depositary share | SSaleDisposed | −96 | $147.11 | −$14,122.56 | 15,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average price of shares sold at prices that ranged from $144.07 to $144.995. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average price of shares sold at prices that ranged from $145 to $145.94. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average price of shares sold at prices that ranged from $146.005 to $146.755. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.